BIO SB Products and Technology for Molecular Pathology
Bio SB performs R&D, production, distribution and marketing of unique products for Immunohistochemistry (IHC), Immunocytochemistry (ICC), Fluorescent in situ hybridization (FISH), Chromogenic in situ hybridization (CISH), Liquid-Based Cytology (LBC) and Polymerase Chain Reaction (PCR) technologies that meet the highest international standards for applications in Molecular Pathology, Cancer Research, Microbiology, Immunology and Genetics. BIO SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP. These guidelines enable us to produce an IVD product that meets the highest in vitro diagnostic standards.
Bio SB helps institutions implement state-of-the-art cancer diagnostics technologies which include:
- IHC and ICC to determine cancer-related protein expression in tissue or cells
- FISH and CISH designed for the evaluation and detection of genetic aberrations such as translocations, deletions, amplifications, chromosomal aneuploidy and gene amplifications.
- PCR to analyze and quantify disease-related nucleic acids. Real Time PCR kits can be used to help professionals determine viral load, monitor disease progression and response to therapy.
- Liquid Cytology, an inexpensive alternative to other liquid-based cytology tests for cervical cancer screening and non-gynecological cytology.
- Equipment for IHC, PCR and LBC that complement the use of our technologies.
In addition to providing its customers with equipment, reagents, and kits, Bio SB also provides training and continual assistance to new and existing laboratories. Bio SB’s skill and knowledge in Immunopathology, lmmunology and Molecular Biology offer the total solution for both cell and tissue staining.